The desumoylating enzyme sentrin-specific protease 3 contributes to myocardial ischemia reperfusion injury

Lingchen Gao; Yichao Zhao; Jie He; Yang Yan; Longwei Xu; Nan Lin; Qingqi Ji; Renyang Tong; Yanan Fu; Yu Gao; Yuanyuan Su; Ancai Yuan; Ben He; Jun Pu

doi:10.1016/j.jgg.2017.12.002

Volume 45 Issue 3

Mar. 2018

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2018 > 45(3): 125-135

PDF( 3769 KB)

The desumoylating enzyme sentrin-specific protease 3 contributes to myocardial ischemia reperfusion injury

doi: 10.1016/j.jgg.2017.12.002

Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

More Information

Corresponding author: E-mail address: heben1025@hotmail.com (Ben He); E-mail address: pujun310@hotmail.com (Jun Pu)
Received Date: 2017-06-30
Accepted Date: 2017-12-27
Rev Recd Date: 2017-12-26

Available Online: 2017-12-29

Publish Date: 2018-03-20

Abstract

Abstract

Sentrin-specific protease 3 (SENP3), a member of the desumoylating enzyme family, is known as a redox sensor and could regulate multiple cellular signaling pathways. However, its implication in myocardial ischemia reperfusion (MIR) injury is unclear. Here, we observed that SENP3 was expressed and upregulated in the mouse heart depending on reactive oxygen species (ROS) production in response to MIR injury. By utilizing siRNA-mediated cardiac specific gene silencing, SENP3 knockdown was demonstrated to significantly reduce MIR-induced infarct size and improve cardiac function. Mechanistic studies indicated that SENP3 silencing ameliorated myocardial apoptosis mainly via suppression of endoplasmic reticulum (ER) stress and mitochondrial-mediated apoptosis pathways. By contrast, adenovirus-mediated cardiac SENP3 overexpression significantly exaggerated MIR injury. Further molecular analysis revealed that SENP3 promoted mitochondrial translocation of dynamin-related protein 1 (Drp1) in reperfused myocardium. In addition, mitochondrial division inhibitor-1 (Mdivi-1), a pharmacological inhibitor of Drp1, significantly attenuated the exaggerated mitochondrial abnormality and cardiac injury by SENP3 overexpression after MIR injury. Taken together, we provide the first direct evidence that SENP3 upregulation pivotally contributes to MIR injury in a Drp1-dependent manner, and suggest that SENP3 suppression may hold therapeutic promise for constraining MIR injury.
- Heart,
- Ischemia reperfusion,
- SUMOylation,
- Sentrin-specific protease

These authors contributed equally to this work.

FullText(HTML)

References(39)

References

[1]	Deftereos, S., Giannopoulos, G., Angelidis, C. et al. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study Circulation, 132 (2015),pp. 1395-1403
[2]	Flotho, A., Melchior, F. Sumoylation: a regulatory protein modification in health and disease Annu. Rev. Biochem., 82 (2013),pp. 357-385
[3]	Fu, J., Yu, H.M., Chiu, S.Y. et al. Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration PLoS Genet., 10 (2014)
[4]	Gu, J., Fan, Y., Liu, X. et al. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1alpha-dependent pathway Cardiovasc. Res., 104 (2014),pp. 83-92
[5]	Guo, C., Hildick, K.L., Luo, J. et al. SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia EMBO J., 32 (2013),pp. 1514-1528
[6]	He, B., Zhao, Y., Xu, L. et al. The nuclear melatonin receptor RORalpha is a novel endogenous defender against myocardial ischemia/reperfusion injury J. Pineal Res., 60 (2016),pp. 313-326
[7]	He, B., Zhao, Y.C., Gao, L.C. et al. Ubiquitin-specific protease 4 is an endogenous negative regulator of pathological cardiac hypertrophy Hypertension, 67 (2016),pp. 1237-1248
[8]	He, Q., Pu, J., Yuan, A. et al. Activation of liver-X-receptor alpha but not liver-X-receptor beta protects against myocardial ischemia/reperfusion injury Circ. Heart Fail., 7 (2014),pp. 1032-1041
[9]	He, Q., Pu, J., Yuan, A. et al. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice Cardiovasc. Diabetol., 13 (2014),p. 149
[10]	Hu, J., Zhang, L., Yang, Y. et al. Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1 J. Pineal Res., 62 (2017)
[11]	Ibanez, B., Heusch, G., Ovize, M. et al. Evolving therapies for myocardial ischemia/reperfusion injury J. Am. Coll. Cardiol., 65 (2015),pp. 1454-1471
[12]	Kolli, N., Mikolajczyk, J., Drag, M. et al. Distribution and paralogue specificity of mammalian deSUMOylating enzymes Biochem. J., 430 (2010),pp. 335-344
[13]	Lee, Y., Gustafsson, A.B. Role of apoptosis in cardiovascular disease Apoptosis, 14 (2009),pp. 536-548
[14]	Mendler, L., Braun, T., Muller, S. The ubiquitin-like SUMO system and heart function: from development to disease Circ. Res., 118 (2016),pp. 132-144
[15]	Mo, Y., Tang, L., Ma, Y. et al. Pramipexole pretreatment attenuates myocardial ischemia/reperfusion injury through upregulation of autophagy Biochem. Biophys. Res. Commun., 473 (2016),pp. 1119-1124
[16]	Movassagh, M., Foo, R.S. Simplified apoptotic cascades Heart Fail. Rev., 13 (2008),pp. 111-119
[17]	Ong, S.B., Subrayan, S., Lim, S.Y. et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury Circulation, 121 (2010),pp. 2012-2022
[18]	Pell, V.R., Chouchani, E.T., Murphy, M.P. et al. Moving forwards by blocking back-flow: the Yin and Yang of MI therapy Circ. Res., 118 (2016),pp. 898-906
[19]	Prudent, J., Zunino, R., Sugiura, A. et al. MAPL SUMOylation of Drp1 stabilizes an ER/mitochondrial platform required for cell death Mol. Cell, 59 (2015),pp. 941-955
[20]	Pu, J., Ding, S., Ge, H. et al. Circulation, 136 (2017),pp. 1462-1473
[21]	Pu, J., Mintz, G.S., Biro, S. et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments J. Am. Coll. Cardiol., 63 (2014),pp. 2220-2233
[22]	Pu, J., Yuan, A., Shan, P. et al. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury Eur. Heart J., 34 (2013),pp. 1834-1845
[23]	Rajan, S., Plant, L.D., Rabin, M.L. et al. Cell, 121 (2005),pp. 37-47
[24]	Saitoh, H., Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3 J. Biol. Chem., 275 (2000),pp. 6252-6258
[25]	Santos-Gallego, C.G., Vahl, T.P., Goliasch, G. et al. Sphingosine-1-hosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia/reperfusion Circulation, 133 (2016),pp. 954-966
[26]	Shao, R., Zhang, F.P., Tian, F. et al. FEBS Lett., 569 (2004),pp. 293-300
[27]	Shen, L., Tatham, M.H., Dong, C. et al. SUMO protease SENP1 induces isomerization of the scissile peptide bond Nat. Struct. Mol. Biol., 13 (2006),pp. 1069-1077
[28]	Wang, J., Feng, X.H., Schwartz, R.J. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity J. Biol. Chem., 279 (2004),pp. 49091-49098
[29]	Wang, J.X., Jiao, J.Q., Li, Q. et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 Nat. Med., 17 (2011),pp. 71-78
[30]	Wang, Y., Yang, J., Yi, J. Redox sensing by proteins: oxidative modifications on cysteines and the consequent events Antioxid. Redox Signal., 16 (2012),pp. 649-657
[31]	Wencker, D., Chandra, M., Nguyen, K. et al. A mechanistic role for cardiac myocyte apoptosis in heart failure J. Clin. Invest., 111 (2003),pp. 1497-1504
[32]	Xie, H., Xu, Q., Jia, J. et al. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux Biochem. Biophys. Res. Commun., 458 (2015),pp. 632-638
[33]	Yan, S., Sun, X., Xiang, B. et al. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90 EMBO J., 29 (2010),pp. 3773-3786
[34]	Yao, T., Ying, X., Zhao, Y. et al. Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy Antioxid. Redox Signal., 22 (2015),pp. 633-650
[35]	Yu, L., Liang, H., Dong, X. et al. Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin J. Pineal Res., 59 (2015),pp. 376-390
[36]	Yu, L., Liang, H., Lu, Z. et al. J. Pineal Res., 59 (2015),pp. 420-433
[37]	Zhao, Y., Xu, L., Ding, S. et al. Novel protective role of the circadian nuclear receptor retinoic acid-related orphan receptor-alpha in diabetic cardiomyopathy J. Pineal Res., 62 (2017)
[38]	Zhao, Y., Xu, L., Qiao, Z. et al. YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor alpha Sci. Rep., 6 (2016),p. 23025
[39]	Zhao, Y.C., Xu, L.W., Ding, S. et al. Nuclear receptor retinoid-related orphan receptor alpha deficiency exacerbates high-fat diet-induced cardiac dysfunction despite improving metabolic abnormality Biochim. Biophys. Acta, 1863 (2017),pp. 1991-2000